Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015)
Prestige Consumer Healthcare (PBH) posted quarterly Amortizatization of Intangibles of $750000.0 for Q1 2015, up 154.24% year-over-year from $295000.0 in Q1 2014, and up 15.56% quarter-over-quarter from $649000.0 in Q4 2014.
Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015) Analysis & Trends
Prestige Consumer Healthcare's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $750000.0 for Q1 2015.
- In Q1 2015, Amortizatization of Intangibles rose 154.24% year-over-year to $750000.0; the TTM figure through Mar 2015 stood at $2.1 million (down 38.83% YoY), while the FY2015 annual figure was $2.1 million, down 38.83% from the prior year.
- Amortizatization of Intangibles for Q1 2015 stood at $750000.0, up from $649000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $3.1 million in Q4 2012, with the low at $144000.0 in Q2 2014.
- The 5-year median for Amortizatization of Intangibles is $404000.0 (2012), against an average of $669411.8.
- The sharpest annual moves came in 2012 and 2014: Amortizatization of Intangibles surged 1244.98% in 2012, then sank 71.99% in 2014.
- Prestige Consumer Healthcare's Amortizatization of Intangibles stood at $229000.0 in 2011, then soared by 1244.98% to $3.1 million in 2012, then retreated by 24.77% to $2.3 million in 2013, then tumbled by 71.99% to $649000.0 in 2014, then increased by 15.56% to $750000.0 in 2015.
- Business Quant data shows PBH's Amortizatization of Intangibles at $750000.0 in Q1 2015, $649000.0 in Q4 2014, and $543000.0 in Q3 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 750,000.00 |
| Mar 31, 2015 | 750,000.00 |
| Dec 31, 2014 | 649,000.00 |
| Dec 31, 2014 | 649,000.00 |
| Sep 30, 2014 | 543,000.00 |
| Sep 30, 2014 | 543,000.00 |
| Jun 30, 2014 | 144,000.00 |
| Jun 30, 2014 | 144,000.00 |
| Mar 31, 2014 | 295,000.00 |
| Mar 31, 2014 | 295,000.00 |
| Dec 31, 2013 | 2.32 Mn |
| Dec 31, 2013 | 2.32 Mn |
| Sep 30, 2013 | 453,000.00 |
| Sep 30, 2013 | 453,000.00 |
| Jun 30, 2013 | 345,000.00 |
| Jun 30, 2013 | 345,000.00 |
| Mar 31, 2013 | 740,000.00 |
| Mar 31, 2013 | 740,000.00 |
| Dec 31, 2012 | 3.08 Mn |
| Dec 31, 2012 | 3.08 Mn |